Call for Abstract
Scientific Program
35th International Diabetes and Healthcare Conference, will be organized around the theme “Building a Sustainable and Inclusive Approach to Diabetes Care and Prevention”
Diabetes 2026 is comprised of keynote and speakers sessions on latest cutting edge research designed to offer comprehensive global discussions that address current issues in Diabetes 2026
Submit your abstract to any of the mentioned tracks.
Register now for the conference by choosing an appropriate package suitable to you.
Diabetes development is driven by complex molecular signaling disruptions over time. Altered insulin transduction pathways reduce cellular glucose uptake efficiency. Persistent metabolic stress promotes glucotoxicity, damaging pancreatic function. Changes in phosphorylation cascades affect receptor sensitivity. Long-term imbalance accelerates systemic complications.
Exploration Points:
- Cellular Signaling Alterations
- Receptor Sensitivity Decline
- Molecular Disease Onset Models
Pancreatic beta cells adapt continuously to metabolic demand. Chronic overload disrupts proinsulin folding, reducing hormone output. Elevated endoplasmic reticulum stress accelerates cell exhaustion. Altered islet cytoarchitecture weakens coordinated secretion. Protective strategies aim to enhance cellular resilience mechanisms. Preserving beta-cell function remains central to long-term disease control.
Research Streams:
- Beta Cell Survival Pathways
- Islet Structural Integrity
- Hormone Secretion Stability
Insulin resistance arises from impaired cellular responsiveness. Increased lipotoxic intermediates interfere with glucose transport. Skeletal muscle exhibits altered mitochondrial bioenergetics under chronic metabolic load. Inflammatory signals modify substrate oxidation balance. Enhancing metabolic plasticity improves glycemic outcomes and slows disease progression.
Focus Areas:
- Tissue Glucose Uptake
- Energy Utilization Shifts
- Resistance Reversal Strategies
Low-grade inflammation sustains metabolic dysfunction. Elevated cytokine polarization disrupts insulin signaling. Immune cells release chemokine gradients that worsen tissue sensitivity. Persistent activation of inflammasome complexes accelerates vascular damage. Modulating immune-metabolic crosstalk is essential for reducing long-term complications.
Discussion Segments:
- Chronic Inflammation Drivers
- Immune Signal Regulation
- Anti-Inflammatory Therapies
Genetic predisposition plays a major role in diabetes susceptibility. Variants influencing allelic penetrance alter glucose regulation. Epigenetic shifts modify chromatin accessibility in metabolic genes. Disrupted transcriptional fidelity affects insulin pathways. Understanding heritability gradients supports early screening and personalized prevention strategies.
Genomic Focus Areas:
- Risk Gene Mapping
- Epigenetic Influence Models
- Predictive Genetic Tools
Pregnancy introduces unique metabolic challenges for women. Placental hormones influence glycemic adaptability. Altered fetoplacental signaling increases maternal insulin demand. Persistent hormonal flux patterns elevate postpartum diabetes risk. Monitoring metabolic imprinting effects improves outcomes for both mother and child.
Maternal Care Modules:
- Pregnancy-Specific Risks
- Post-Delivery Metabolic Recovery
- Fetal Health Correlations
Pediatric diabetes requires age-specific diagnostic and care strategies. Developing systems exhibit altered immune ontogeny. Fluctuating autoantibody titers indicate early disease onset. Growth phases affect endocrine maturation timing. Early intervention supports long-term metabolic programming and reduces lifelong complications.
Pediatric Focus:
- Early Detection Indicators
- Growth-Related Metabolic Needs
- Family-Centered Care Models
Diabetes significantly elevates cardiovascular risk. Chronic hyperglycemia promotes endothelial dysfunction. Lipid imbalance drives atherogenic remodeling of blood vessels. Reduced vascular compliance indices impair circulation. Targeting cardiometabolic coupling lowers mortality and improves heart health outcomes.
Heart Health Domains:
- Vascular Risk Assessment
- Lipid–Glucose Interactions
- Preventive Cardiac Care
Nerve damage often develops silently in diabetes patients. Glucose excess disrupts axonal transport dynamics. Reduced blood flow induces neuroischemic stress. Altered myelin integrity patterns impair nerve conduction. Therapies aim to restore neural metabolic balance and preserve sensory function.
Neurological Sections:
- Sensory Loss Mechanisms
- Pain Management Approaches
- Nerve Regeneration Research
Kidney damage progresses gradually in diabetic individuals. Elevated glucose alters glomerular filtration kinetics. Protein leakage reflects basement membrane thickening. Inflammatory stress worsens renal microcirculation. Early intervention preserves nephron viability markers and delays renal failure.
Renal Care Themes:
- Early Kidney Damage Detection
- Filtration Function Monitoring
- Renoprotective Therapies
Diabetic retinopathy remains a leading cause of vision loss. Microvascular injury causes retinal capillary dropout. Hypoxia stimulates angiogenic factor release. Structural damage alters ocular perfusion dynamics. Preventive screening ensures visual acuity sustainability and early treatment success.
Ophthalmic Focus Areas:
- Retinal Imaging Advances
- Vision Preservation Techniques
- Microvascular Protection
Excess body weight intensifies metabolic dysfunction. Adipose tissue releases adipokine imbalances that impair insulin action. Altered energy homeostasis loops disrupt glucose control. Chronic weight gain affects satiety signaling pathways. Improving caloric utilization efficiency supports diabetes prevention.
Metabolic Focus Domains:
- Weight-Related Risk Models
- Appetite Regulation Science
- Lifestyle Intervention Outcomes
Digital technologies are transforming diabetes care. Continuous monitoring improves glycemic variability analytics. Smart platforms use algorithmic dose optimization. Remote systems enhance patient adherence metrics. Integration supports real-time decision frameworks for personalized management.
Technology Domains:
- Wearable Innovations
- Data-Driven Care Models
- Remote Patient Monitoring
Artificial intelligence enables predictive and personalized care. Machine learning identifies pattern recognition thresholds. Advanced models improve risk stratification accuracy. Automation supports clinical decision augmentation. Ethical implementation ensures transparent model interpretability and clinical trust.
AI Application Areas:
- Predictive Analytics
- Personalized Treatment Planning
- Ethical AI Deployment
Nutrition directly influences blood glucose regulation. Macronutrient balance affects postprandial glycemia curves. Fiber intake modifies intestinal glucose diffusion. Meal timing impacts circadian metabolic alignment. Precision diets enhance nutrient-response predictability and patient adherence.
Nutritional Science Domains:
- Dietary Pattern Analysis
- Meal Timing Strategies
- Personalized Nutrition Models
Regular physical activity improves metabolic health. Muscle contraction stimulates glucose transporter translocation. Training enhances oxidative capacity thresholds. Exercise reduces systemic insulin demand. Sustained movement promotes metabolic endurance adaptation and long-term glucose control.
Fitness & Activity Modules:
- Exercise Prescription Models
- Activity-Based Risk Reduction
- Lifestyle Integration Strategies
Psychological health strongly influences diabetes outcomes. Chronic stress alters neuroendocrine feedback loops. Emotional burden affects treatment compliance behaviors. Social support improves self-management resilience. Addressing stigma enhances quality-of-life indices and care engagement.
Behavioral Health Areas:
- Stress Management Tools
- Patient Motivation Models
- Community Support Systems
Health disparities significantly impact diabetes outcomes worldwide. Socioeconomic barriers drive care delivery inequities. Cultural factors influence health literacy gradients. Limited resources reduce preventive outreach effectiveness. Equity-focused policies promote inclusive care frameworks and sustainable solutions.
Equity & Policy Discussions:
- Access Improvement Strategies
- Community-Based Interventions
- Policy-Driven Solutions
Pharmacological innovation continues to improve diabetes care. Novel agents enhance receptor agonism specificity. Combination therapies increase therapeutic synergy profiles. Optimized dosing reduces adverse effect incidence. Progress supports long-term efficacy stability and patient safety.
Therapeutic Development Areas:
- Drug Development Pipelines
- Safety Optimization
- Treatment Personalization
Future diabetes care emphasizes integrated and global solutions. Systems biology advances multi-omic data convergence. Personalized medicine enables precision intervention mapping. Collaboration accelerates translational research velocity. Sustainable models ensure global health impact scalability and innovation.
Future Pathways:
- Emerging Research Frontiers
- Integrated Care Systems
- Global Collaboration Models

